PRINCETON, N.J., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in the following investor conferences:
- On September 9, 2021, Carrie Anderson, executive vice president and chief financial officer will present at the Wells Fargo 2021 Virtual Healthcare Conference at 11:20am ET.
- On September 13, 2021, Carrie Anderson, executive vice president and chief financial officer will present at the Morgan Stanley 19th Annual Global Healthcare Conference at 1:15pm ET.
Webcast information can be found on the Company’s website at Investor Relations.
About Integra LifeSciences
Integra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®, DuraGen®, DuraSeal®, Gentrix®, ICP Express®, Integra®, MatriStem® UBM, MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®, PriMatrix®, SurgiMend®, TCC-EZ® and VersaTru®. For the latest news and information about Integra and its products, please visit www.integralife.com.
Investor Relations:
Michael Beaulieu
(609) 529-4812
michael.beaulieu@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
Source:
Integra LifeSciences Holdings Corporation2021 GlobeNewswire, Inc., source Press Releases
INTEGRA LIFESCIENCES HOLDINGS CORPORATION 
